McCarthy Asset Management’s Eli Lilly LLY Stock Holding History

McCarthy Asset Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-822	Closed	-$744K	–	39
2024 Q2	$744K	Buy	822 +30	+4%	+$24K	0.44%	22
2024 Q1	$616K	Hold	792	–	–	0.38%	23
2023 Q4	$462K	Hold	792	–	–	0.3%	26
2023 Q3	$425K	Hold	792	–	–	0.31%	25
2023 Q2	$371K	Hold	792	–	–	0.25%	27
2023 Q1	$272K	Hold	792	–	–	0.18%	29
2022 Q4	$290K	Hold	792	–	–	0.2%	28
2022 Q3	$256K	Hold	792	–	–	0.2%	30
2022 Q2	$257K	Hold	792	–	–	0.21%	31
2022 Q1	$227K	Hold	792	–	–	0.16%	33
2021 Q4	$219K	Buy	792 +3	+0.4%	+$761	0.15%	35
2021 Q3	$182K	Hold	789	–	–	0.14%	38
2021 Q2	$181K	Hold	789	–	–	0.13%	40
2021 Q1	$147K	Hold	789	–	–	0.12%	43
2020 Q4	$133K	Buy	+789	New	+$118K	0.11%	46

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

McCarthy Asset Management's LLY Position: Q3 2024 in Review

McCarthy Asset Management sold out of Eli Lilly (LLY) in Q3 2024, closing a stake of 822 shares — an estimated $744K sold.

McCarthy Asset Management first reported a position in LLY in Q4 2020 and held it in 15 quarters. The position peaked at $744K in Q2 2024. 3,658 funds tracked by Wall St. Rank hold LLY as of Q3 2024.

McCarthy Asset Management reported no remaining Eli Lilly position as of Q3 2024 after selling out during the quarter.
McCarthy Asset Management sold 822 Eli Lilly shares in Q3 2024, an estimated $744K.
McCarthy Asset Management first reported a position in Eli Lilly in Q4 2020 and held it in 15 quarters.
McCarthy Asset Management's Eli Lilly position peaked at $744K in Q2 2024.
3,658 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2024.

Based on McCarthy Asset Management's 13F filing for Q3 2024, filed 18 Nov 2024.